↓ Skip to main content

Bisphosphonates in multiple myeloma: a network meta-analysis

Overview of attention for article published in Cochrane database of systematic reviews, May 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs
1 blog
twitter
16 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
104 Dimensions

Readers on

mendeley
136 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bisphosphonates in multiple myeloma: a network meta-analysis
Published in
Cochrane database of systematic reviews, May 2012
DOI 10.1002/14651858.cd003188.pub3
Pubmed ID
Authors

Rahul Mhaskar, Jasmina Redzepovic, Keith Wheatley, Otavio Augusto Camara Clark, Branko Miladinovic, Axel Glasmacher, Ambuj Kumar, Benjamin Djulbegovic

Abstract

Bisphosphonates are specific inhibitors of osteoclastic activity and used in the treatment of patients with multiple myeloma (MM). While bisphosphonates are shown to be effective in reducing vertebral fractures and pain, their role in improving overall survival (OS) remains unclear. This is an update of a Cochrane review first published in 2002 and previously updated in 2010.

Twitter Demographics

The data shown below were collected from the profiles of 16 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Egypt 1 <1%
Netherlands 1 <1%
Taiwan 1 <1%
United States 1 <1%
Unknown 130 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 18%
Student > Ph. D. Student 19 14%
Student > Master 17 13%
Other 14 10%
Student > Doctoral Student 13 10%
Other 33 24%
Unknown 16 12%
Readers by discipline Count As %
Medicine and Dentistry 83 61%
Agricultural and Biological Sciences 10 7%
Nursing and Health Professions 7 5%
Mathematics 3 2%
Economics, Econometrics and Finance 3 2%
Other 11 8%
Unknown 19 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2016.
All research outputs
#879,676
of 14,198,500 outputs
Outputs from Cochrane database of systematic reviews
#2,675
of 10,882 outputs
Outputs of similar age
#6,833
of 122,825 outputs
Outputs of similar age from Cochrane database of systematic reviews
#14
of 102 outputs
Altmetric has tracked 14,198,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,882 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.7. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,825 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.